Dr Christian Behrenbruch

This profile gathers the share dealings of Dr Christian Behrenbruch in Telix Pharmaceuticals Limited, where the filings describe the role as board member. The record holds 2 filings, for trades running from 29 April 2026 to 26 May 2026.

Purchases make up the whole of the open-market record (2 purchases, €608k). The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 1 June 2026 with an open-market purchase in Telix Pharmaceuticals Limited. Source: insider filings from ASX. Past trades are no guide to future returns.